Poolbeg Pharma

POLB · AIM · Health Care · mcap £52m · 6.9p

Beta Briefing, track record and bull & bear case are not ready for Poolbeg Pharma yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 34 companies are already wired into a briefing: browse them.

Financials · LTM to 30 Jun 26

Source: results 29 Sep 26 ↗

Revenue: –
Operating profit: −£5.7m
Net income: −£5.5m
Free cash flow: −£5.4m
Net cash: £4.8m
Market cap: £52.7m
EV / EBIT: –
FCF yield: −10.2%
Price / book: 7.9×

Latest half-year · H1 26 vs H1 25 results 29 Sep 26 ↗

Operating profit: −£2.1m
Net income: −£1.9m
Cash from operations: −£2.9m

Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

Income statement Cash flow Balance sheet

Annual Half-yearly

Latest report: H1 26 (six months to 30 Jun 26), published 29 Sep 26 · read the results ↗

£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source

	LTM Jun 26	FY 25
Operating profit	(5.7)	(6.0)
Amortisation	0.1	0.1
Share-based payments	0.2	0.5
Profit before tax	(5.5)	(5.8)
Tax	0.1	0.1
Net income (owners)	(5.5)	(5.7)
EPS basic	(0.8p)	(0.9p)
EPS diluted	(0.8p)	(0.9p)

	H1 26	vs H1 25	H2 25	H1 25
Operating profit	(2.1)	n/m	(3.7)	(2.3)
Amortisation	0.0	n/m	0.0	0.0
Share-based payments	0.0	−87%	0.2	0.3
Profit before tax	(2.0)	n/m	(3.5)	(2.2)
Tax	0.0	n/m	0.0	0.1
Net income (owners)	(1.9)	n/m	(3.5)	(2.2)
EPS basic	(0.3p)	–	(0.5p)	(0.4p)
EPS diluted	(0.3p)	–	(0.5p)	(0.4p)

	LTM Jun 26	FY 25
Cash from operations	(5.2)	(4.8)
Capex (intangibles)	(0.1)	(0.1)
Shares issued	(0.0)	4.5

	H1 26	vs H1 25	H2 25	H1 25
Cash from operations	(2.9)	n/m	(2.3)	(2.5)
Capex (intangibles)	(0.1)	n/m	(0.1)	(0.0)
Shares issued	0.0	−100%	(0.0)	4.5

	Latest Jun 26	FY 25
Trade receivables	0.6	0.6
Cash	4.8	7.7
Current assets	5.5	8.3
Total assets	7.1	9.9
Trade payables	0.4	1.3
Current liabilities	0.4	1.3
Total liabilities	0.4	1.3
Total equity	6.7	8.6

	H1 26	H2 25	H1 25
Trade receivables	0.6	0.6	0.7
Cash	4.8	7.7	10.0
Current assets	5.5	8.3	10.7
Total assets	7.1	9.9	12.4
Trade payables	0.4	1.3	0.4
Current liabilities	0.4	1.3	0.4
Total liabilities	0.4	1.3	0.4
Total equity	6.7	8.6	11.9

Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.

Company filings. Not investment advice.